AllianceBernstein’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
AllianceBernstein's RIGL Position: Q3 2026 in Review
AllianceBernstein held its Rigel Pharmaceuticals (RIGL) position steady in Q3 2026 at 32,033 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2210.
AllianceBernstein first reported a position in RIGL in Q2 2013 and has held it in 54 quarters since. The position peaked at $4.31M in Q3 2018. 170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- AllianceBernstein held 32,033 shares of Rigel Pharmaceuticals worth $1.54M as of Q3 2026.
- AllianceBernstein left its Rigel Pharmaceuticals share count unchanged in Q3 2026.
- Rigel Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q3 2026, its #2210 holding.
- AllianceBernstein first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 54 quarters since.
- AllianceBernstein's Rigel Pharmaceuticals position peaked at $4.31M in Q3 2018.
- 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on AllianceBernstein's 13F filing for Q3 2026, filed 16 Nov 2026.